BRIEF

on Jaguar Health, Inc. (NASDAQ:JAGX)

Jaguar Health Launches Neonorm Dog on Amazon

Stock price chart of Jaguar Health, Inc. (EBR:JAGX) showing fluctuations.

Jaguar Health, Inc. has introduced Neonorm Dog on Amazon, expanding its Neonorm franchise. This plant-based product supports normal stool consistency and GI fluid balance in dogs. Neonorm Dog builds on existing products, Neonorm Foal and Neonorm Calf, and extends Jaguar's reach in the companion animal market. The product is aimed at pet owners seeking non-prescription, botanical options for dog digestive health.

The Chief Business Officer of Jaguar, Ian Wendt, emphasizes the importance of making Neonorm Dog easily accessible. The product is part of Jaguar's strategy to offer differentiated digestive support, leveraging scientific expertise to address common issues like loose stools in dogs.

Neonorm products contain botanical extracts from the Croton lechleri tree. Jaguar expects further distribution via other online platforms and animal health retailers like Chewy. Jaguar positions Neonorm Dog as a convenient solution to a widespread concern among dog owners.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Jaguar Health, Inc. news